Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CytomX Therapeutics (CTMX) Preferred Dividend Payments: 2013-2015

Historic Preferred Dividend Payments for CytomX Therapeutics (CTMX) over the last 3 years, with Dec 2015 value amounting to $6.7 million.

  • CytomX Therapeutics' Preferred Dividend Payments fell 53.34% to $558,000 in Q4 2015 from the same period last year, while for Dec 2015 it was $6.7 million, marking a year-over-year change of. This contributed to the annual value of $6.7 million for FY2015, which is 46.85% up from last year.
  • As of FY2015, CytomX Therapeutics' Preferred Dividend Payments stood at $6.7 million, which was up 46.85% from $4.6 million recorded in FY2014.
  • CytomX Therapeutics' 5-year Preferred Dividend Payments high stood at $6.7 million for FY2015, and its period low was $3.8 million during FY2013.
  • Over the past 3 years, CytomX Therapeutics' median Preferred Dividend Payments value was $4.6 million (recorded in 2014), while the average stood at $5.0 million.
  • Data for CytomX Therapeutics' Preferred Dividend Payments shows a peak YoY spiked of 46.85% (in 2015) over the last 5 years.
  • Yearly analysis of 3 years shows CytomX Therapeutics' Preferred Dividend Payments stood at $3.8 million in 2013, then increased by 21.73% to $4.6 million in 2014, then soared by 46.85% to $6.7 million in 2015.